Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

CBLB-612 demonstrates efficacy in primate study

April 24, 2007

Antisoma and Novartis sign global licensing agreement for AS-1404

April 24, 2007

Preclinical development of AT-13387, an HSP90 inhibitor, proceeds towards IND filing

April 24, 2007

Dual FAK/Pyk2 kinase inhibitor displays promising preclinical profile

April 24, 2007

Preclinical data reported for new irofulven analogue MGI-4184

April 24, 2007

Sirtex Medical to sponsor FAST trial

April 24, 2007

Potent and selective c-Met inhibitor described at AACR by Merck team

April 23, 2007

MAb targeting DR5 induces apoptosis and tumor regression without toxicity

April 23, 2007

Full FDA approval for DepoCyt for lymphomatous meningitis

April 23, 2007

BGC-945 emerges as a tumor-targeted agent with minimal toxicity

April 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...